{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T13:10:22Z","timestamp":1790082622338,"version":"4.0.1"},"reference-count":84,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,12,13]],"date-time":"2021-12-13T00:00:00Z","timestamp":1639353600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Tumour Virus Research"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.tvr.2021.200231","type":"journal-article","created":{"date-parts":[[2021,12,15]],"date-time":"2021-12-15T20:49:22Z","timestamp":1639601362000},"page":"200231","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Oesophageal carcinoma: The prevalence of DNA tumour viruses and therapy"],"prefix":"10.1016","volume":"13","author":[{"given":"Sile","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3443-4806","authenticated-orcid":false,"given":"Ho Yin","family":"Luk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chichao","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zigui","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6360-4608","authenticated-orcid":false,"given":"Paul Kay Sheung","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9772-2971","authenticated-orcid":false,"given":"Siaw Shi","family":"Boon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.tvr.2021.200231_bib1","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA A Cancer J. Clin."},{"issue":"1","key":"10.1016\/j.tvr.2021.200231_bib2","doi-asserted-by":"crossref","first-page":"141","DOI":"10.3390\/cancers13010141","article-title":"Global burden, risk factors, and trends of esophageal cancer: an analysis of cancer registries from 48 countries","volume":"13","author":"Huang","year":"2021","journal-title":"Cancers"},{"issue":"2","key":"10.1016\/j.tvr.2021.200231_bib3","article-title":"The incidence and mortality of esophageal cancer and their relationship to development in Asia","volume":"4","author":"Pakzad","year":"2016","journal-title":"Ann. Transl. Med."},{"issue":"10","key":"10.1016\/j.tvr.2021.200231_bib4","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1136\/gutjnl-2012-302412","article-title":"A global assessment of the oesophageal adenocarcinoma epidemic","volume":"62","author":"Edgren","year":"2013","journal-title":"Gut"},{"issue":"6","key":"10.1016\/j.tvr.2021.200231_bib5","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1086\/670629","article-title":"National estimates of central line-associated bloodstream infections in critical care patients","volume":"34","author":"Wise","year":"2013","journal-title":"Infect. Control Hosp. Epidemiol."},{"issue":"1","key":"10.1016\/j.tvr.2021.200231_bib6","first-page":"8","article-title":"Tobacco cancer of the oral cavity and pharynx","volume":"97","author":"Rassekh","year":"2001","journal-title":"W. Va. Med. J."},{"key":"10.1016\/j.tvr.2021.200231_bib7","series-title":"Novartis Foundation Symposium. 2007","article-title":"The role of acetaldehyde in alcohol-associated cancer of the gastrointestinal tract","author":"Seitz","year":"1999"},{"issue":"11","key":"10.1016\/j.tvr.2021.200231_bib8","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1056\/NEJM199903183401101","article-title":"Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma","volume":"340","author":"Lagergren","year":"1999","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.tvr.2021.200231_bib9","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1158\/1055-9965.EPI-07-0748","article-title":"Abdominal obesity and the risk of esophageal and gastric cardia carcinomas","volume":"17","author":"Corley","year":"2008","journal-title":"Cancer Epidemiol. Epidemiol. Biomark"},{"issue":"2","key":"10.1016\/j.tvr.2021.200231_bib10","doi-asserted-by":"crossref","first-page":"e180","DOI":"10.1016\/S2214-109X(19)30488-7","article-title":"Global burden of cancer attributable to infections in 2018: a worldwide incidence analysis","volume":"8","author":"de Martel","year":"2020","journal-title":"Lancet Global Health"},{"issue":"2","key":"10.1016\/j.tvr.2021.200231_bib11","first-page":"80","article-title":"Review of HPV-related diseases and cancers","volume":"40","author":"Brianti","year":"2017","journal-title":"New Microbiol."},{"issue":"8","key":"10.1016\/j.tvr.2021.200231_bib12","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.3748\/wjg.v11.i8.1200","article-title":"Human papillomavirus in squamous cell carcinoma of esophagus in a high-risk population","volume":"11","author":"Farhadi","year":"2005","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.tvr.2021.200231_bib13","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.bpobgyn.2017.08.006","article-title":"Epidemiology and burden of HPV-related disease","volume":"47","author":"Serrano","year":"2018","journal-title":"Best Pract. Res. Clin. Obstet. Gynaecol."},{"issue":"4","key":"10.1016\/j.tvr.2021.200231_bib14","first-page":"291","article-title":"Squamous cell papilloma of the esophagus: a tumour probably caused by human papilloma virus (HPV)","volume":"5","author":"Syrj\u00e4nen","year":"1982","journal-title":"Diagn. Histopathol."},{"issue":"3","key":"10.1016\/j.tvr.2021.200231_bib15","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1111\/apt.12574","article-title":"Systematic review with meta-analysis: the association between human papillomavirus infection and oesophageal cancer","volume":"39","author":"Li","year":"2014","journal-title":"Aliment. Pharmacol. Ther."},{"issue":"1","key":"10.1016\/j.tvr.2021.200231_bib16","first-page":"1","article-title":"Human papillomavirus type 18 oncoproteins exert their oncogenicity in esophageal and tongue squamous cell carcinoma cell lines distinctly","volume":"19","author":"Boon","year":"2019","journal-title":"BMC Cancer"},{"key":"10.1016\/j.tvr.2021.200231_bib17","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.2147\/CMAR.S232388","article-title":"The emerging roles of miR-125b in cancers","volume":"12","author":"Wang","year":"2020","journal-title":"Cancer Manag. Res."},{"issue":"1","key":"10.1016\/j.tvr.2021.200231_bib18","doi-asserted-by":"crossref","DOI":"10.1186\/s40659-020-00301-7","article-title":"\u03b2-Catenin: oncogenic role and therapeutic target in cervical cancer","volume":"53","author":"Wang","year":"2020","journal-title":"Biol. Res."},{"issue":"6","key":"10.1016\/j.tvr.2021.200231_bib19","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1177\/0022034518771923","article-title":"Emerging insights into Wnt\/\u03b2-catenin signaling in head and neck cancer","volume":"97","author":"Alamoud","year":"2018","journal-title":"J. Dent. Res."},{"issue":"10","key":"10.1016\/j.tvr.2021.200231_bib20","first-page":"13687","article-title":"HPV-16 E6 promotes cell growth of esophageal cancer via downregulation of miR-125b and activation of Wnt\/\u03b2-catenin signaling pathway","volume":"8","author":"Zang","year":"2015","journal-title":"Int. J. Clin. Exp. Pathol."},{"issue":"7","key":"10.1016\/j.tvr.2021.200231_bib21","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1038\/ajg.2013.94","article-title":"Transcriptionally active human papillomavirus is strongly associated with Barrett's dysplasia and esophageal adenocarcinoma","volume":"108","author":"Rajendra","year":"2013","journal-title":"Am. J. Gastroenterol."},{"issue":"10","key":"10.1016\/j.tvr.2021.200231_bib22","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1002\/ijc.30896","article-title":"Active human papillomavirus involvement in Barrett's dysplasia and oesophageal adenocarcinoma is characterized by wild\u2010type p53 and aberrations of the retinoblastoma protein pathway","volume":"141","author":"Rajendra","year":"2017","journal-title":"Int. J. Cancer"},{"issue":"9","key":"10.1016\/j.tvr.2021.200231_bib23","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.1093\/annonc\/mdy251","article-title":"Plasma HPV cell-free DNA monitoring in advanced HPV-associated oropharyngeal cancer","volume":"29","author":"Hanna","year":"2018","journal-title":"Ann. Oncol."},{"issue":"12","key":"10.1016\/j.tvr.2021.200231_bib24","article-title":"Circulating human papillomavirus DNA detection in Barrett's dysplasia and esophageal adenocarcinoma","volume":"32","author":"Parameshwaran","year":"2019","journal-title":"Dis. Esophagus"},{"key":"10.1016\/j.tvr.2021.200231_bib25","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.canep.2016.01.014","article-title":"Human papillomavirus not detected in esophageal adenocarcinoma tumor specimens","volume":"41","author":"Antonsson","year":"2016","journal-title":"Cancer Epidemiol"},{"issue":"7636","key":"10.1016\/j.tvr.2021.200231_bib26","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/nature20805","article-title":"Integrated genomic characterization of oesophageal carcinoma","volume":"541","author":"Network","year":"2017","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.tvr.2021.200231_bib27","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/nyas.14509","article-title":"Human papillomavirus infection in esophageal squamous cell carcinoma and esophageal adenocarcinoma: a concise review","volume":"1482","author":"Rajendra","year":"2020","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"7","key":"10.1016\/j.tvr.2021.200231_bib28","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1097\/MEG.0000000000000868","article-title":"The prevalence of viral agents in esophageal adenocarcinoma and Barrett's esophagus: a systematic review","volume":"29","author":"Kunzmann","year":"2017","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.tvr.2021.200231_bib29","series-title":"Human Papillomavirus Laboratory Manual","author":"Organization","year":"2010"},{"issue":"11","key":"10.1016\/j.tvr.2021.200231_bib30","doi-asserted-by":"crossref","first-page":"2691","DOI":"10.3390\/cancers13112691","article-title":"Current updates on cancer-causing types of human papillomaviruses (HPVs) in East, Southeast, and South Asia","volume":"13","author":"Xia","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.tvr.2021.200231_bib31","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2018.00211","article-title":"Epstein-barr virus epidemiology, Serology, and genetic variability of LMP-1 oncogene among healthy population: an update","volume":"8","author":"Smatti","year":"2018","journal-title":"Front. Oncol."},{"issue":"23","key":"10.1016\/j.tvr.2021.200231_bib32","doi-asserted-by":"crossref","first-page":"6010","DOI":"10.1158\/0008-5472.CAN-19-0615","article-title":"Integrated pan-cancer map of EBV-associated neoplasms reveals functional host-virus interactions","volume":"79","author":"Chakravorty","year":"2019","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.tvr.2021.200231_bib33","doi-asserted-by":"crossref","DOI":"10.7189\/jogh.10.010405","article-title":"Risk factors for Epstein Barr virus-associated cancers: a systematic review, critical appraisal, and mapping of the epidemiological evidence","volume":"10","author":"Bakkalci","year":"2020","journal-title":"J. Global Health"},{"issue":"1","key":"10.1016\/j.tvr.2021.200231_bib34","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.bbrc.2016.04.070","article-title":"Epstein-Barr virus latency type and spontaneous reactivation predict lytic induction levels","volume":"474","author":"Phan","year":"2016","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.tvr.2021.200231_bib35","author":"Frappier"},{"issue":"1","key":"10.1016\/j.tvr.2021.200231_bib36","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1111\/j.1442-2050.2005.00423.x","article-title":"Detection of HSV and EBV in esophageal carcinomas from a high-incidence area in Shantou China","volume":"18","author":"Wu","year":"2005","journal-title":"Dis. Esophagus"},{"issue":"6","key":"10.1016\/j.tvr.2021.200231_bib37","first-page":"1731","article-title":"Prevalence and association of human papillomavirus 16, Epstein-Barr virus, herpes simplex virus-1 and cytomegalovirus infection with human esophageal carcinoma: a case-control study","volume":"25","author":"Zhang","year":"2011","journal-title":"Oncol. Rep."},{"issue":"6","key":"10.1016\/j.tvr.2021.200231_bib38","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1111\/j.1442-2050.2005.00522.x","article-title":"Absence of Epstein-Barr virus in esophageal squamous cell carcinoma","volume":"18","author":"Sunpaweravong","year":"2005","journal-title":"Dis. Esophagus"},{"issue":"10","key":"10.1016\/j.tvr.2021.200231_bib39","doi-asserted-by":"crossref","first-page":"2834","DOI":"10.1111\/j.1572-0241.1999.01425.x","article-title":"Detection of Epstein-Barr virus in esophageal squamous cell carcinoma in Taiwan","volume":"94","author":"Wang","year":"1999","journal-title":"Am. J. Gastroenterol."},{"issue":"8","key":"10.1016\/j.tvr.2021.200231_bib40","first-page":"1809","article-title":"The association of Epstein-Barr virus DNA with esophageal squamous cell carcinoma","volume":"13","author":"Jenkins","year":"1996","journal-title":"Oncogene"},{"issue":"3","key":"10.1016\/j.tvr.2021.200231_bib41","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s00430-002-0128-z","article-title":"Esophageal cancer in Germany is associated with Epstein-Barr-virus but not with papillomaviruses","volume":"192","author":"Awerkiew","year":"2003","journal-title":"Med. Microbiol. Immunol."},{"issue":"4","key":"10.1016\/j.tvr.2021.200231_bib42","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s00430-004-0233-2","article-title":"Presence of Epstein-Barr virus in esophageal cancer is restricted to tumor infiltrating lymphocytes","volume":"194","author":"Awerkiew","year":"2005","journal-title":"Med. Microbiol. Immunol."},{"issue":"12","key":"10.1016\/j.tvr.2021.200231_bib43","first-page":"1111","article-title":"Esophageal squamous cell carcinomas arising in patients from a high-risk area of North China lack an association with Epstein-Barr virus","volume":"8","author":"Wang","year":"1999","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"issue":"5C","key":"10.1016\/j.tvr.2021.200231_bib44","first-page":"3935","article-title":"Evaluation of HPV, CMV, HSV and EBV in esophageal squamous cell carcinomas from a high-incidence area of China","volume":"20","author":"Chang","year":"2000","journal-title":"Anticancer Res."},{"issue":"4","key":"10.1016\/j.tvr.2021.200231_bib45","first-page":"353","article-title":"Prevalence and association of human papillomavirus, Epstein-Barr virus and Merkel Cell polyomavirus with neoplastic esophageal lesions in northern Iran","volume":"9","author":"Yahyapour","year":"2018","journal-title":"Caspian. J. Intern. Med."},{"issue":"1","key":"10.1016\/j.tvr.2021.200231_bib46","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1177\/172460080502000102","article-title":"Evaluation of the prevalence of human papillomavirus and Epstein-Barr virus in esophageal squamous cell carcinomas","volume":"20","author":"Lyronis","year":"2005","journal-title":"Int. J. Biol. Markers"},{"issue":"1","key":"10.1016\/j.tvr.2021.200231_bib47","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jjco\/27.1.1","article-title":"Absence of human papillomavirus-16 and -18 DNA and Epstein-Barr virus DNA in esophageal squamous cell carcinoma","volume":"27","author":"Mizobuchi","year":"1997","journal-title":"Jpn. J. Clin. Oncol."},{"issue":"2-3","key":"10.1016\/j.tvr.2021.200231_bib48","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1385\/IJGC:33:2-3:165","article-title":"Epstein-Barr virus association is rare in esophageal squamous cell carcinoma","volume":"33","author":"Yanai","year":"2003","journal-title":"Int. J. Gastrointest. Cancer"},{"issue":"9","key":"10.1016\/j.tvr.2021.200231_bib49","doi-asserted-by":"crossref","first-page":"924","DOI":"10.7326\/0003-4819-119-9-199311010-00010","article-title":"Gastrointestinal cytomegalovirus disease","volume":"119","author":"Goodgame","year":"1993","journal-title":"Ann. Intern. Med."},{"issue":"1","key":"10.1016\/j.tvr.2021.200231_bib50","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13099-021-00418-4","article-title":"Cytomegalovirus\u2010associated esophagitis on early esophageal cancer in immunocompetent host: a case report","volume":"13","author":"Murakami","year":"2021","journal-title":"Gut Pathog."},{"issue":"6","key":"10.1016\/j.tvr.2021.200231_bib51","first-page":"1731","article-title":"Prevalence and association of human papillomavirus 16, Epstein-Barr virus, herpes simplex virus-1 and cytomegalovirus infection with human esophageal carcinoma: a case-control study","volume":"25","author":"Zhang","year":"2011","journal-title":"Oncol. Rep."},{"issue":"1","key":"10.1016\/j.tvr.2021.200231_bib52","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1111\/j.1442-2050.2005.00423.x","article-title":"Detection of HSV and EBV in esophageal carcinomas from a high-incidence area in Shantou China","volume":"18","author":"Wu","year":"2005","journal-title":"Dis. Esophagus"},{"issue":"2","key":"10.1016\/j.tvr.2021.200231_bib53","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0304-3835(97)00312-1","article-title":"Human papillomavirus, cytomegalovirus and herpes simplex virus infections for cervical cancer in Taiwan","volume":"120","author":"Han","year":"1997","journal-title":"Cancer Lett."},{"issue":"2","key":"10.1016\/j.tvr.2021.200231_bib54","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1002\/ijc.2910540211","article-title":"Prognostic significance of human papillomavirus genomes (type\u201016,\u201018) and aberrant expression of p53 protein in human esophageal cancer","volume":"54","author":"Furihata","year":"1993","journal-title":"Int. J. Cancer"},{"issue":"2","key":"10.1016\/j.tvr.2021.200231_bib55","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2019.21189","article-title":"Association of biomarkers for human papillomavirus with survival among adults with Barrett high-grade dysplasia and esophageal adenocarcinoma","volume":"3","author":"Rajendra","year":"2020","journal-title":"JAMA Netw. Open"},{"issue":"1","key":"10.1016\/j.tvr.2021.200231_bib56","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2407-6-94","article-title":"High-risk human papilloma virus (HPV) and survival in patients with esophageal carcinoma: a pilot study","volume":"6","author":"Dreilich","year":"2006","journal-title":"BMC Cancer"},{"issue":"26","key":"10.1016\/j.tvr.2021.200231_bib57","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1056\/NEJMra1314530","article-title":"Esophageal carcinoma","volume":"371","author":"Rustgi","year":"2014","journal-title":"N. Engl. J. Med."},{"issue":"9864","key":"10.1016\/j.tvr.2021.200231_bib58","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/S0140-6736(12)60643-6","article-title":"Oesophageal carcinoma","volume":"381","author":"Pennathur","year":"2013","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.tvr.2021.200231_bib59","doi-asserted-by":"crossref","DOI":"10.1001\/jamaoncol.2018.0013","article-title":"Safety and efficacy of pembrolizumab monotherapy in patients with previously treated advanced gastric and gastroesophageal junction cancer: phase 2 clinical KEYNOTE-059 trial","volume":"4","author":"Fuchs","year":"2018","journal-title":"JAMA Oncol."},{"issue":"11","key":"10.1016\/j.tvr.2021.200231_bib60","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1016\/S1470-2045(19)30626-6","article-title":"Nivolumab versus chemotherapy in patients with advanced oesophageal squamous cell carcinoma refractory or intolerant to previous chemotherapy (ATTRACTION-3): a multicentre, randomised, open-label, phase 3 trial","volume":"20","author":"Kato","year":"2019","journal-title":"Lancet Oncol."},{"issue":"9319","key":"10.1016\/j.tvr.2021.200231_bib61","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1016\/S0140-6736(02)08651-8","article-title":"Surgical resection with or without preoperative chemotherapy in oesophageal cancer: a randomised controlled trial","volume":"359","author":"Working","year":"2002","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.tvr.2021.200231_bib62","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa055531","article-title":"Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer","volume":"355","author":"Cunningham","year":"2006","journal-title":"N. Engl. J. Med."},{"issue":"7","key":"10.1016\/j.tvr.2021.200231_bib63","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1200\/JCO.2007.12.9593","article-title":"Phase III trial of trimodality therapy with cisplatin, fluorouracil, radiotherapy, and surgery compared with surgery alone for esophageal cancer: CALGB 9781","volume":"26","author":"Tepper","year":"2008","journal-title":"J. Clin. Oncol.: Off. J. Am. Soc. Clin. Oncol."},{"issue":"4","key":"10.1016\/j.tvr.2021.200231_bib64","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/nrc3239","article-title":"The blockade of immune checkpoints in cancer immunotherapy","volume":"12","author":"Pardoll","year":"2012","journal-title":"Nat. Rev. Cancer"},{"issue":"4","key":"10.1016\/j.tvr.2021.200231_bib65","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1158\/1535-7163.MCT-14-0983","article-title":"PD-L1 expression as a predictive biomarker in cancer immunotherapy","volume":"14","author":"Patel","year":"2015","journal-title":"Mol. Cancer Therapeut."},{"issue":"8","key":"10.1016\/j.tvr.2021.200231_bib66","doi-asserted-by":"crossref","first-page":"2947","DOI":"10.1158\/1078-0432.CCR-04-1469","article-title":"Clinical significance of programmed death-1 ligand-1 and programmed death-1 ligand-2 expression in human esophageal cancer","volume":"11","author":"Ohigashi","year":"2005","journal-title":"Clin. Cancer Res."},{"issue":"5","key":"10.1016\/j.tvr.2021.200231_bib67","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/S1470-2045(17)30181-X","article-title":"Nivolumab treatment for oesophageal squamous-cell carcinoma: an open-label, multicentre, phase 2 trial","volume":"18","author":"Kudo","year":"2017","journal-title":"Lancet Oncol."},{"issue":"3","key":"10.1016\/j.tvr.2021.200231_bib68","doi-asserted-by":"crossref","first-page":"203","DOI":"10.2217\/imt-2019-0153","article-title":"Immunotherapy for esophageal cancer: a 2019 update","volume":"12","author":"Schizas","year":"2020","journal-title":"Immunotherapy"},{"key":"10.1016\/j.tvr.2021.200231_bib69","series-title":"Nivolumab and Ipilimumab for Second-Line Therapy in Elderly Patients with Advanced Esophageal Squamous Cell Cancer: Safety Interim Analysis of the RAMONA Trial","author":"Hartel","year":"2021"},{"issue":"5","key":"10.1016\/j.tvr.2021.200231_bib70","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1158\/1078-0432.CCR-09-2870","article-title":"Modulation of lymphocyte regulation for cancer therapy: a phase II trial of tremelimumab in advanced gastric and esophageal adenocarcinoma","volume":"16","author":"Ralph","year":"2010","journal-title":"Clin. Cancer Res."},{"issue":"19","key":"10.1016\/j.tvr.2021.200231_bib71","doi-asserted-by":"crossref","first-page":"5671","DOI":"10.1158\/1078-0432.CCR-17-0025","article-title":"Efficacy of sequential ipilimumab monotherapy versus best supportive care for unresectable locally advanced\/metastatic gastric or gastroesophageal junction cancer","volume":"23","author":"Bang","year":"2017","journal-title":"Clin. Cancer Res."},{"issue":"10111","key":"10.1016\/j.tvr.2021.200231_bib72","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1016\/S0140-6736(17)31827-5","article-title":"Nivolumab in patients with advanced gastric or gastro-oesophageal junction cancer refractory to, or intolerant of, at least two previous chemotherapy regimens (ONO-4538-12, ATTRACTION-2): a randomised, double-blind, placebo-controlled, phase 3 trial","volume":"390","author":"Kang","year":"2017","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.tvr.2021.200231_bib73","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1093\/annonc\/mdh231","article-title":"A phase II study of single-agent docetaxel in patients with metastatic esophageal cancer","volume":"15","author":"Muro","year":"2004","journal-title":"Ann. Oncol."},{"issue":"6","key":"10.1016\/j.tvr.2021.200231_bib74","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1007\/s00280-010-1422-x","article-title":"A phase II study of paclitaxel by weekly 1-h infusion for advanced or recurrent esophageal cancer in patients who had previously received platinum-based chemotherapy","volume":"67","author":"Kato","year":"2011","journal-title":"Cancer Chemother. Pharmacol."},{"issue":"15_suppl","key":"10.1016\/j.tvr.2021.200231_bib75","doi-asserted-by":"crossref","DOI":"10.1200\/jco.2008.26.15_suppl.4510","article-title":"A randomized trial of postoperative adjuvant chemotherapy with cisplatin and 5-fluorouracil versus neoadjuvant chemotherapy for clinical stage II\/III squamous cell carcinoma of the thoracic esophagus (JCOG 9907)","volume":"26","author":"Igaki","year":"2008","journal-title":"J. Clin. Oncol."},{"issue":"5","key":"10.1016\/j.tvr.2021.200231_bib76","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/nrc1074","article-title":"5-fluorouracil: mechanisms of action and clinical strategies","volume":"3","author":"Longley","year":"2003","journal-title":"Nat. Rev. Cancer"},{"issue":"10","key":"10.1016\/j.tvr.2021.200231_bib77","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1080\/14656566.2017.1334764","article-title":"Current and future treatment options for esophageal cancer in the elderly","volume":"18","author":"Bollschweiler","year":"2017","journal-title":"Expet Opin. Pharmacother."},{"issue":"10184","key":"10.1016\/j.tvr.2021.200231_bib78","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1016\/S0140-6736(18)32557-1","volume":"393","author":"Al-Batran","year":"2019","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.tvr.2021.200231_bib79","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S1470-2045(14)70028-2","article-title":"Definitive chemoradiotherapy with FOLFOX versus fluorouracil and cisplatin in patients with oesophageal cancer (PRODIGE5\/ACCORD17): final results of a randomised, phase 2\/3 trial","volume":"15","author":"Conroy","year":"2014","journal-title":"Lancet Oncol."},{"issue":"6","key":"10.1016\/j.tvr.2021.200231_bib80","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1002\/bjs.7455","article-title":"Meta\u2010analysis of neoadjuvant treatment modalities and definitive non\u2010surgical therapy for oesophageal squamous cell cancer","volume":"98","author":"Kranzfelder","year":"2011","journal-title":"Br. J. Surg."},{"issue":"33","key":"10.1016\/j.tvr.2021.200231_bib81","doi-asserted-by":"crossref","first-page":"3874","DOI":"10.1200\/JCO.2015.60.7465","article-title":"Randomized multicenter phase II study of modified docetaxel, cisplatin, and fluorouracil (DCF) versus DCF plus growth factor support in patients with metastatic gastric adenocarcinoma: a study of the US Gastric Cancer Consortium","volume":"33","author":"Shah","year":"2015","journal-title":"J. Clin. Oncol."},{"issue":"5","key":"10.1016\/j.tvr.2021.200231_bib82","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1093\/qjmed\/hcr262","article-title":"Cytomegalovirus: recent progress in understanding pathogenesis and control","volume":"105","author":"Emery","year":"2012","journal-title":"QJM: Int. J. Med."},{"issue":"1","key":"10.1016\/j.tvr.2021.200231_bib83","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13256-016-0947-y","article-title":"Cytomegalovirus esophagitis developing during chemoradiotherapy for esophageal cancer: two case reports","volume":"10","author":"Umemoto","year":"2016","journal-title":"J. Med. Case Rep."},{"issue":"9","key":"10.1016\/j.tvr.2021.200231_bib84","first-page":"2054","article-title":"Radiofrequency hyperthermia-enhanced herpes simplex virus-thymidine kinase\/ganciclovir direct intratumoral gene therapy of esophageal squamous cancers","volume":"6","author":"Shi","year":"2016","journal-title":"Am. Journal.Cancer Res."}],"container-title":["Tumour Virus Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666679021000215?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666679021000215?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T03:52:39Z","timestamp":1763005959000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666679021000215"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":84,"alternative-id":["S2666679021000215"],"URL":"https:\/\/doi.org\/10.1016\/j.tvr.2021.200231","relation":{},"ISSN":["2666-6790"],"issn-type":[{"value":"2666-6790","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Oesophageal carcinoma: The prevalence of DNA tumour viruses and therapy","name":"articletitle","label":"Article Title"},{"value":"Tumour Virus Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tvr.2021.200231","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"200231"}}